Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

OSI receives patent protection for its gene transcription-regulating drugs

July 20, 1998

Trega identifies lead compounds in R&D collaboration with Ono

July 17, 1998

Bioject enters vaccine delivery agreement with Merck

July 17, 1998

Nexell's Isolex technology receives U.S. patent protection; FDA requests more data

July 16, 1998

Cyclacel licenses novel drug delivery technology from CNRS

July 15, 1998

MacroChem and American Home Products sign collaborative agreement

July 13, 1998

Iomed and Novartis to discontinue research collaboration

July 9, 1998

Sheffield and Elan finalize pulmonary drug delivery collaboration

July 9, 1998

Oxford Molecular Group enters research collaboration with Mitsubishi Chemical

July 6, 1998

Abgenix and Genentech expand collaboration

July 2, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...